Different daily inhaler routines for mild asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests two ways to use common asthma inhalers (budesonide and formoterol) to see if a simple, everyday approach can control mild asthma symptoms better and with less need for rescue medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 70 years old and have been newly diagnosed with mild asthma (not severe or long-standing).
- Your doctor has confirmed that your airways respond to treatments, either by a breathing test (bronchodilator test) or a challenge test.
- Your lung function (FEV1) is at least 80% of normal for your age and size.
- You have not smoked much (less than 10 pack-years) and have not smoked in the last 6 months.
- You are not allergic to budesonide, formoterol, or albuterol (common asthma medicines).
- You do not have other serious lung conditions like COPD, asthma-related infections in the last 2 months, or major heart/liver/kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding an immune-modulating tablet (made from bacteria) to a standard combination inhaler for asthma improves asthma control more than the inhaler alone. The study aims to see if this combination helps reduce symptoms and lung inflammation.
This trial tests a new inhaled medicine called PA9159 for adults with moderate asthma. It compares the medicine to a placebo to see if it safely improves breathing and controls asthma symptoms.
This trial tests an inhaled asthma medication, PA9159, in adults with stable or mild-to-moderate asthma. It aims to see if the drug improves lung function and is safe. You may qualify if you have asthma with some airflow limitation and have not had recent severe flare-ups.
This study tests a new combination inhaler for people with asthma. It may help control symptoms and improve breathing. Participants will either get the study inhaler or a standard treatment, and their asthma will be monitored closely.
This study tests a new combination inhaler (budesonide/albuterol) against another asthma inhaler in adults whose asthma is not well controlled on their current medications. It aims to see if the new inhaler can reduce serious asthma attacks and improve symptoms.
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
Hear when a new Bronchial Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.